1-(tert-Butoxycarbonyl)octahydro-3aH-pyrrolo[3,2-c]pyridine-3a-carboxylic acid

Catalog No. :
ACMGJB178
CAS No. :
1334416-52-2
Molecular Formula :
C13H22N2O4
Molecular Weight :
270.33

IUPAC Name:1-(tert-butoxycarbonyl)octahydro-3aH-pyrrolo[3,2-c]pyridine-3a-carboxylic acid

1-(tert-Butoxycarbonyl)octahydro-3aH-pyrrolo[3,2-c]pyridine-3a-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$937.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)octahydro-3aH-pyrrolo[3,2-c]pyridine-3a-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)octahydro-3aH-pyrrolo[3,2-c]pyridine-3a-carboxylic acid
MDL No.MFCD19686933
Molecular FormulaC13H22N2O4
Molecular Weight270.33
SMILESO=C(C12CNCCC1N(C(OC(C)(C)C)=O)CC2)O
InChI KeyNXSFCOFBYPGVMY-UHFFFAOYSA-N
Synonymtert-BUTYL 3,7-DIAZABICYCLO[4,3,0]NONANE-7-DICARBOXYLATE;1-[(tert-butoxy)carbonyl]-octahydro-1h-pyrrolo[3,2-c]pyridine-3a-carboxylic acid;1H-Pyrrolo[3,2-c]pyridine-1,3a(7aH)-dicarboxylic acid, hexahydro-, 1-(1,1-dimethylethyl) ester;1-(tert-butoxycarbonyl)octahydro-3ah-pyrrolo[3,2-c]pyridine-3a-carboxylic acid
CAS No.1334416-52-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMGJB178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGJB178 route product structure diagram
    ACMGJB1781334416-52-2
Inquiry

2. ACMGJB178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMGJB178 route product structure diagram
    ACMGJB1781334416-52-2
Inquiry

Comments (0)